NCT07268326

Brief Summary

The goal of this clinical trial is to evaluate the effect of a plant-based diet (PBD) intervention in adults with Rheumatoid Arthritis (RA) on disease activity. The investigators hypothesize that if patients with RA follow a 100% PBD over a 16-week period it will lead to improvements in: \- Disease activity (measured by DAS28), including reduction in symptoms and overall improvements in health-related quality of life. The effects of the PBD will be compared to a habitual diet, that includes no dietary changes. Participants in the intervention group will:

  • Receive weekly delivery of food boxes which include plant-based food items
  • Receive a daily multivitamin supplement
  • Receive continuous dietetic guidance
  • Participate in a practical cooking class to get an introduction to a PBD
  • Participate in three online supervisions throughout the intervention period Participants in the control group will follow the same plan for the project visits at the hospital but will be restricted to continue their habitual diet. Thus, not performing any dietary changes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Dec 2025Dec 2028

First Submitted

Initial submission to the registry

November 18, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

November 18, 2025

Last Update Submit

March 17, 2026

Conditions

Keywords

Rheumatoid ArthritisPlant-basedDietary interventionClinical nutrition

Outcome Measures

Primary Outcomes (1)

  • Disease activity measured by DAS28

    The Disease Activity Score 28 (DAS28) is a composite index used to assess disease activity in patients with rheumatoid arthritis. The DAS28 is a quantification of tender and swollen joints within the hands, shoulders, elbows, wrists, and knees. These assessments, in conjunction with CRP values obtained from blood samples and the self-reported global Visual Analog Scale (VAS) score, will be incorporated into the computation of DAS28. The DAS28 ranges from 0 to 10, with higher scores indicating higher disease activity.

    16 weeks

Secondary Outcomes (1)

  • Ultrasound - supportive of the primary outcome

    16 weeks

Other Outcomes (18)

  • Inflammatory biomarkers

    16 weeks

  • Cholesterol

    16 weeks

  • Glucose

    16 weeks

  • +15 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL
Other: Plant-based diet

Control group

NO INTERVENTION

Interventions

The intervention is a 100% plant-based diet, and a daily multivitamin supplement. Participants in the intervention group will receive weekly food delivery to their household. Moreover, they will participate in a practical cooking workshop with other participants of the intervention group. Furthermore, they will have three online supervisions with relevant project staff.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • DAS28 score ≤3.2, and without swollen joints
  • RA diagnosis of minimum one year
  • Stable pharmacological treatment for at least four months and with no planned change in treatment within eight weeks

You may not qualify if:

  • Smokers
  • Diabetes mellitus
  • Pregnancy / planned pregnancy
  • Prednisolone treatment
  • DAS28 above 3.2
  • Current dietary habits resembling intervention diet (e.g., PBD lifestyle)
  • Food allergies and intolerances
  • Unable to understand the informed consent and study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bispebjerg and Frederiksberg Hospital, Center for Clinical Research and Prevention

Frederiksberg, Denmark

RECRUITING

The Department of Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet, Glostrup

Glostrup Municipality, Denmark

RECRUITING

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Diet, Plant-Based

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Nikita Misella Hansen, Postdoc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Project nurses
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 5, 2025

Study Start

December 15, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations